Diseases of liver. Liver disease, unspecified
Conditions
Interventions
Intervention 1: Intervention group: L-carnitine oral vial containing 2 grams of L-carnitine drug, 1 orally every 12 hours, for 5 days. This drug is produced by the Bonyan Salamat Kasari pharmaceutica
Sponsors
Bonyan Salamat Kasra pharmaceutical company
Bagheiat-allah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Have read and signed a written informed consent to participate in the study Age between 18-90 years old; The patient's Child-Pugh score is category B or C;
Exclusion criteria
Exclusion criteria: Pregnancy; Breastfeeding; Participate in another clinical trial at the same time; History of previous allergies to any of the components of the drug;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AST serum level. Timepoint: Before and after intervention. Method of measurement: Blood sample.;ALT serum level. Timepoint: Before and after intervention. Method of measurement: Blood sample. | — |
Secondary
| Measure | Time frame |
|---|---|
| Bilirubin serum level. Timepoint: Before and after the intervention. Method of measurement: Blood sample.;Child-Pugh score. Timepoint: Before and after the intervention. Method of measurement: Child-Pugh score classification. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactparisa kianpour
Tehran University of Medical Sciences
Outcome results
None listed